Yale researchers identify T cells active against advanced melanoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study led by Yale Cancer Center and Department of Neurology researchers demonstrated that a blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

In recent months, several directors of cancer centers, appearing on The Directors, a segment of The Cancer Letter Podcast, mentioned that their institutions are increasingly providing small grants—typically in the range of $50,000—to scientists to enable them to keep their labs open.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login